Literature DB >> 10770786

Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.

K A Craig-Mylius1, A A Weiss.   

Abstract

Pertussis toxin accumulates in the periplasm of Bordetella pertussis prior to secretion, and we examined its fate following treatment with antimicrobial agents. Both antibiotics that inhibit protein synthesis (erythromycin and chloramphenicol), transcription (rifampin), or cell wall biosynthesis (cefoperazone and piperacillin) and magnesium sulfate (which inhibits transcription of pertussis toxin, but not bacterial growth) did not prevent release of preformed toxin. In contrast, agents that affect bacterial membranes, such as polymyxin B, lidocaine, procaine, and ethanol, inhibited release of preformed pertussis toxin. These results suggest new protein synthesis is not required for pertussis toxin secretion, but a functional membrane complex is required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770786      PMCID: PMC89879          DOI: 10.1128/AAC.44.5.1383-1386.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

2.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

Review 3.  Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

Authors:  M Pittman
Journal:  Rev Infect Dis       Date:  1979 May-Jun

4.  Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release.

Authors:  M N Neely; D I Friedman
Journal:  Mol Microbiol       Date:  1998-06       Impact factor: 3.501

5.  Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.

Authors:  K Grif; M P Dierich; H Karch; F Allerberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-11       Impact factor: 3.267

Review 6.  Studies on the mechanism of action of local anesthetics with phospholipid model membranes.

Authors:  D Papahadjopoulos
Journal:  Biochim Biophys Acta       Date:  1972-04-18

7.  Antimicrobial activity of local anesthetics: lidocaine and procaine.

Authors:  R M Schmidt; H S Rosenkranz
Journal:  J Infect Dis       Date:  1970-06       Impact factor: 5.226

8.  Molecular characterization of an operon required for pertussis toxin secretion.

Authors:  A A Weiss; F D Johnson; D L Burns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Procaine, a local anesthetic interacting with the cell membrane, inhibits the processing of precursor forms of periplasmic proteins in Escherichia coli.

Authors:  C Lazdunski; D Baty; J M Pagès
Journal:  Eur J Biochem       Date:  1979-05-02

Review 10.  Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome.

Authors:  H Trachtman; E Christen
Journal:  Curr Opin Pediatr       Date:  1999-04       Impact factor: 2.856

View more
  5 in total

1.  Growth phase influences complement resistance of Bordetella pertussis.

Authors:  Michael G Barnes; Alison A Weiss
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis.

Authors:  Trevor H Stenson; Alison A Weiss
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  Reduced glutathione is required for pertussis toxin secretion by Bordetella pertussis.

Authors:  Trevor H Stenson; Angela K Patton; Alison A Weiss
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

4.  Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.

Authors:  L M Schaeffer; A A Weiss
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Genotypes and phenotypes of Shiga toxin-producing Escherichia coli (STEC) in Abeokuta, Southwestern Nigeria.

Authors:  Olugbenga Adekunle Olowe; Bukola W Aboderin; Olayinka O Idris; Victor O Mabayoje; Oluyinka O Opaleye; O Catherine Adekunle; Rita Ayanbolade Olowe; Paul Akinniyi Akinduti; Olusola Ojurongbe
Journal:  Infect Drug Resist       Date:  2014-10-15       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.